RBC Capital Markets adjusted its stance on Intra-Cellular Therapies shares, downgrading the biopharmaceutical company from Outperform to Sector Perform. The firm, however, raised its price target on ...

RBC Capital Markets adjusted their outlook on Morgan Stanley (NYSE:MS) shares, raising the price target from $122.00 to ...

In a report released on January 17, Jon Arfstrom from RBC Capital maintained a Buy rating on Webster Financial (WBS – Research Report), with a ...

Morgan Stanley analyst Robert Koh maintained a Buy rating on AGL Energy Limited (AGLNF – Research Report) today and set a price target of ...

RBC Capital Markets analyst Maurice Choy identifies relative “safer havens” in the yield-heavy energy infrastructure sector, ...

https://www.tipranks.com/news/the-fly/wintrust-financial-price-target-raised-to-152-from-148-at-rbc-capital Morgan Stanley analyst Jeffrey Adelson raised the firm’s ...

Daniel Fannon; Analyst; Jefferies & Company Inc. Gerard Cassidy; Analyst; RBC Capital Markets ...

Alphabet (NASDAQ:GOOGL – Get Free Report) had its price objective increased by Morgan Stanley from $205.00 to $215.00 in a ...

Research analysts at BMO Capital Markets began coverage on shares of Toast (NYSE:TOST – Get Free Report) in a report released ...